Global In Vitro Diagnostic (IVD) Procedure Volumes Report 2023-2028: The Gold Standard for Sizing Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care Market Opportunities - ResearchAndMarkets.com
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers.
The market analysis in the report saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner.
Scope
Data statistics appearing in this report correlate to IVD procedures based on commercially sold and distributed tests. Procedures that employ laboratory-developed tests (LDTs) and tests implemented for research purposes only are excluded from the analysis.
Global volumes of various IVD procedures are presented in millions and reflect the evaluation of a single analyte, marker, or other variable of interest. It should be noted that some IVD tests involve more than one procedure as they provide for the analysis of multiple analytes.
Global sales of IVD products are expressed in current United States dollars and reflect sales for the year 2023 and forecasts for the 2028 period. A table that measures the total amount of IVD product sales against the total volume of IVD procedures is presented for each major testing category.
The IVD procedures report presents projections covering the 2023 to 2028 period for:
The global number of IVD procedures by type (self and professional point-of-care, clinical chemistry, immunoassay, molecular, hematology, coagulation, microbiology, blood banking, and histology/cytology)
The total number of IVD tests by region and selected countries
The average and total worldwide cost of various IVD tests
Key Topics Covered:
Chapter One: Executive Summary
Introduction
IVD Procedure Volume Estimate and Forecast
Scope & Methodology
Chapter Two: Introduction
Overview
Industry Trends
COVID-19
Demographic Trends
Global Population and Aging
Workforce Reduction
Increase in Chronic Diseases
Personalized Medicine
New Infectious Disease Threats
Tickborne Diseases (TBDs)
Zika
Chagas
Dengue
Ebola
Chikungunya
Middle East Respiratory Syndrome-Coronavirus (MERS-CoV)
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
This release should be read with the Company's Financial Statements and Management Discussion & Analysis ("MD&A"), available at www.tasekomines.com and filed on www.sedarplus.com. Except where otherwise noted, all currency amounts are stated in...
Viatris Inc. , a global healthcare company, recently launched Unmind as part of its global wellbeing program, Elevate. Unmind is a leading provider of workplace mental health solutions designed by psychologists to help individuals understand and be...
Acadia Realty Trust ("Acadia" or the "Company") today announced that its Board of Trustees has declared a cash dividend of $0.18 per common share for the quarter ended June 30, 2024. The quarterly dividend is payable on July 15, 2024 to holders of...
Toromont Industries Ltd. today reported its financial results for the first quarter ended March 31, 2024.
Three months ended March 31
($ millions, except per share amounts)
2024
2023
% change
Revenue
$
1,016.3
$
1,046.4
(3) %
Operating income
$...
The "Asia-Pacific Wearable Patches Market: Focus on Usage Type, Application, End User, and Country - Analysis and Forecast, 2023-2031" report has been added to ResearchAndMarkets.com's offering.
The Asia-Pacific wearable patches market was valued...